Log in to save to my catalogue

Methylphenidate in Borderline Personality Disorder: Assessing Its Therapeutic Potential and Limitati...

Methylphenidate in Borderline Personality Disorder: Assessing Its Therapeutic Potential and Limitati...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2ad679ab45d541a180d8a1e3f0a82894

Methylphenidate in Borderline Personality Disorder: Assessing Its Therapeutic Potential and Limitations

About this item

Full title

Methylphenidate in Borderline Personality Disorder: Assessing Its Therapeutic Potential and Limitations

Publisher

Switzerland: MDPI AG

Journal title

Life (Basel, Switzerland), 2025-02, Vol.15 (3), p.380

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Impulsivity is increasingly recognized as a transdiagnostic feature that spans multiple psychiatric disorders, including borderline personality disorder (BPD), bipolar disorder, and substance use disorders. In BPD, impulsive behaviors manifest as substance misuse, risky sexual activity, self-injury, and other maladaptive patterns. This review artic...

Alternative Titles

Full title

Methylphenidate in Borderline Personality Disorder: Assessing Its Therapeutic Potential and Limitations

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2ad679ab45d541a180d8a1e3f0a82894

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2ad679ab45d541a180d8a1e3f0a82894

Other Identifiers

ISSN

2075-1729

E-ISSN

2075-1729

DOI

10.3390/life15030380

How to access this item